Showing results (11-20 of 58) with videos related to
Sort By:
Pageof 6
Annals of Medicine|July 11, 2023
The prognostic significance of skin involvement in breast cancer patients with chest wall recurrenceDanyang Zhou, Mei Li, Fei Xu, et al.Cancer Medicine|December 28, 2023
Construction of immune score and its prognostic value in invasive lobular carcinoma of the breast using computational pathology analysisLiye Wang, Peng Sun, Fei Xu, et al.Annals of Medicine|August 16, 2021
Clinical genomic profiling to identify actionable alterations for very early relapsed triple-negative breast cancer patients in the Chinese populationLiye Wang, Qinglian Zhai, Qianyi Lu, et al.Anti-Cancer Drugs|February 2, 2023
Significant response to margetuximab in Chinese HER2-positive metastatic breast cancer patient who progressed after second-line targeted therapyJiaping Li, Qianyi Lu, Hanxing Zhou, et al.Journal of Personalized Medicine|February 25, 2023
Current Situation of Diagnosis and Treatment of HER2-Positive Metastatic Breast Cancer Patients in China: A Nationwide Cross-Sectional Survey of DoctorsKuikui Jiang, Danyang Zhou, Ruoxi Hong, et al.Journal of Translational Medicine|September 24, 2025
A dual-branch deep learning network for circulating tumor cells classificationChao Han, Jiaquan Lin, Yanfang Liang, et al.Breast Cancer Research and Treatment|October 7, 2022
Long-term survival after sentinel lymph node biopsy or axillary lymph node dissection in pN0 breast cancer patients: a population-based studyQiufan Zheng, Hanjia Luo, Wen Xia, et al.BMC Cancer|August 29, 2024
The prognostic significance of circulating tumor cell enumeration and HER2 expression by a novel automated microfluidic system in metastatic breast cancerLiye Wang, Ruoxi Hong, Simei Shi, et al.Anti-Cancer Drugs|August 26, 2014
Efficacy of platinum-based chemotherapy in triple-negative breast cancer patients with metastases confined to the lungs: a single-institute experienceRuoxi Hong, Fei Ma, Binghe Xu, et al.BMC Cancer|September 11, 2016
53BP1 depletion causes PARP inhibitor resistance in ATM-deficient breast cancer cellsRuoxi Hong, Fei Ma, Weimin Zhang, et al.Pageof 6